发明名称 METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY 124-
摘要 The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.
申请公布号 HK1170690(A1) 申请公布日期 2016.09.15
申请号 HK20120111647 申请日期 2012.11.16
申请人 PTC Therapeutics Inc. 发明人 Hirawat, Samit;Miller, Langdon
分类号 A61K;A61P 主分类号 A61K
代理机构 代理人
主权项
地址